Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Pharyngitis Treatment Market Expected to Grow Between 2025 And 2029?
In recent times, there has been a consistent expansion in the pharyngitis treatment market size. It is predicted to escalate from $2.27 billion in 2024 to $2.37 billion in 2025, following a Compound Annual Growth Rate (CAGR) of 4.2%. The growth experienced historically is due to factors such as the increased prevalence and incidence of flu, a higher number of pharyngitis cases, better understanding of the condition, improved healthcare accessibility, and growing disposable incomes.
The market size for pharyngitis treatment is anticipated to experience robust growth in the upcoming years, with a projection to hit$3 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.1%. The surge during the predicted period can be credited to the adoption of speedy point-of-care tests, the need for tailor-made medicine, the commonness of antibiotic resistance, and increasing emphasis on hand hygiene. Significant trends throughout this period include advancements in the R&D of pharyngitis treatments, the integration of digital health technologies, and the implementation of telehealth.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp
What are the Fundamental Drivers and Innovations Shaping the Pharyngitis Treatment Market?
The anticipated growth of the pharyngitis treatment market is linked to the increasing spread of strep throat. This infectious bacterial condition predominantly influences the throat and tonsils. Proper and timely therapy for strep throat with antibiotics can lessen symptoms, avert further complications, and diminish the potential for spreading the infection to others. As an illustration, data from the Centers for Disease Control and Prevention, a government organization in the U.S., highlights that each year, about 14,000 to 25,000 incidents of invasive group A strep illness transpire domestically. Additionally, strep diseases account for approximately 5.2 million outpatient visits and 2.8 million antibiotic prescriptions on an annual basis. Hence, the escalating transmission of strep throat fuels the presence and expansion of the pharyngitis treatment market.
How Is the Pharyngitis Treatment Market Segmented?
The pharyngitis treatmentmarket covered in this report is segmented –
1) By Drug Class: Beta Lactams; Macrolides; Cephalosporins; Fluoroquinolones; Tetracycline; Other Drug Classes
2) By Source of Infection: Viral; Bacterial
3) By Modes Of Delivery: Oral; Intravenous; Intramuscular; Other Modes Of Delivery
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Beta Lactams: Penicillins; Amoxicillin; Ampicillin
2) By Macrolides: Erythromycin; Azithromycin; Clarithromycin
3) By Cephalosporins: Cefuroxime; Ceftriaxone; Cefdinir
4) By Fluoroquinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin
5) By Tetracycline: Doxycycline; Minocycline; Tetracycline
6) By Other Drug Classes: Clindamycin; Sulfonamides; Carbapenems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12937&type=smp
Which Regions Are Driving the Next Phase of the Pharyngitis Treatment Market Growth?
North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Trends Are Shaping the Future of the Pharyngitis Treatment Market?
Key players in the pharyngitis treatment market are concentrating on the creation of innovative products such as oral monotherapy to improve patient adherence and provide efficient, easy-to-use treatment options. Oral monotherapy involves the oral administration of a single drug or medication to treat a specific disease or condition, using only one therapeutic agent as opposed to a combination of several treatments to achieve the desired therapeutic effect. For example, in December 2023, Novartis AG, a pharmaceutical corporation based in Switzerland, received FDA approval for Fabhalta (iptacopan), making it the first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria (PNH). This landmark, reached on [date], marks a substantial progression by offering a new treatment alternative that boosts hemoglobin levels, eliminating the need for blood transfusions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report
How Is the Pharyngitis Treatment Market Defined and What Are Its Core Parameters?
Pharyngitis treatment refers to the management and care provided to individuals experiencing inflammation of the mucous membranes of the oropharynx, commonly known as the throat. Pharyngitis can be caused by a variety of reasons, including bacterial or viral infections, allergies, trauma, malignancy, reflux, and some poisons.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12937
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model